A detailed history of Qtron Investments LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Qtron Investments LLC holds 9,662 shares of EXAS stock, worth $520,975. This represents 0.09% of its overall portfolio holdings.

Number of Shares
9,662
Holding current value
$520,975
% of portfolio
0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $409,958 - $684,359
9,662 New
9,662 $657,000
Q4 2023

Feb 12, 2024

BUY
$59.06 - $75.72 $241,968 - $310,224
4,097 New
4,097 $303,000
Q2 2022

Aug 10, 2022

SELL
$35.61 - $76.23 $125,204 - $268,024
-3,516 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$57.56 - $82.54 $202,380 - $290,210
3,516 New
3,516 $246,000
Q2 2021

Aug 11, 2021

SELL
$93.66 - $139.27 $301,866 - $448,867
-3,223 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$116.57 - $155.01 $375,705 - $499,597
3,223 New
3,223 $425,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.54B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.